Merck KGaA Names James Stewart CIO
James Stewart named CIO of Merck KGaA.
Merck KGaA announced that James Stewart will become CIO of the Merck Group in October 2013. As CIO, Stewart will report to Kai Beckmann, member of Merck KGaA’s Executive Board. Stewart succeeds Frédéric Wohlwend, who has decided to pursue opportunities outside Merck.
James Stewart joined the biopharmaceutical division of Merck KGaA in 2011. Prior to joining Merck KGaA, he had a career with MSD (in the U.S.: Merck & Co.), where he started in Human Resources and progressed through several global business and functional leadership roles.
Source: Merck KGaA
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
